View all Webinars

Schwegman Lundberg & Woessner

Close     Close Mobile Menu

Categories

Recent

Schwegman in Top 30 Firms in its Size Bracket in Law360’s 2020 Diversity Snapshot
Schwegman Lundberg & Woessner is pleased to be among the...
Registration Now Available for Data Monetization Webinar Series
Technology in a wide range of industries now has the...
Sharing Innovative Ideas to Fight COVID-19
In the fight against the coronavirus, individuals, families, medical facilities,...
Join SLW Institute for Complimentary Diversity & Inclusion Training on September 8
Ideal for those with a sense of humor who want...
Destination IP Virtual Summit Offers an Online Journey
This August, the Destination IP Virtual Summit gave participants a...
Stay Connected with a Summer of Complimentary Webinars
This summer, the SLW Institute is providing a wide range...

Warren Woessner to Speak at Bio IP & Diagnostics Symposium

Warren Woessner, founding shareholder of Schwegman, will be speaking at the Bio IP & Diagnostics Symposium (Bio IPDx) on September 19, 2017, in Alexandria, VA.

Dr. Woessner will be speaking alongside Dr. Leslie Fischer of Novartis and Hans Sauer of Biotechnology Innovation Organization in a panel-style discussion titled “The Walls Are Closing In – The Bleak Future of Claims Reciting Natural ‘Correlations’ and Products of Nature.”  The three will discuss how recent developments regarding section 101 may once again increase patentability in this technology space.

Warren’s practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters. In addition, he has served as an expert witness and also works in mediation of inventorship disputes and solutions for complex prosecution problems.

This seminar will be held at the Westin Alexandria from 7:30 am – 2:15 pm.

 

  Back to All News